2020
Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors
Kim J, Zimmerman M, Hong J. Liver transplantation in the treatment of unresectable hepatic metastasis from neuroendocrine tumors. Journal Of Gastrointestinal Oncology 2020, 11: 601-608. PMID: 32655939, PMCID: PMC7340808, DOI: 10.21037/jgo.2019.11.03.Peer-Reviewed Original ResearchPost-OLT outcomesOrthotopic liver transplantationNeuroendocrine tumorsLiver metastasesLiver transplantationTreatment of unresectable hepatic metastasesPatients of neuroendocrine tumorsRecurrence-free patient survivalUnresectable hepatic metastasesPrediction of survival outcomesPrimary neuroendocrine tumorsUnresectable liver metastasesReview patient selection criteriaLiver neuroendocrine tumorsRate of recurrencePatient selection criteriaHepatic metastasesPrognostic factorsRare neoplasmsPost-OLTDefinitive treatmentMetastatic spreadSurvival outcomesPatient survivalMultiple tumors
2018
A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients
Zimmerman M, Selim M, Kim J, Kozeniecki M, Hong J. A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients. Transplantation Proceedings 2018, 50: 2619-2621. PMID: 30348452, DOI: 10.1016/j.transproceed.2018.03.066.Peer-Reviewed Original ResearchConceptsOrthotopic liver transplantationPost-OLT outcomesHigh-acuity patientsLiver transplantationProgression of liver diseasePerceived poor outcomesCritical care modelHighest survival benefitSevere comorbid conditionsTransplant accessSeverity of illnessSurvival benefitCare modelProlonged waiting timesPoor outcomeLife-saving transplantsHigh acuity patientsLiver diseaseComorbid conditionsTransplantationPatientsAcuity patientsHigh-acuityOrganic crisisOutcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply